Medicenna Therapeutics Corp. (MDNAF) stock
MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)
Close on Oct 19, 2026
Medicenna Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2023 it was 65M, up 19.2% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | 65M | +19.2% |
| FY2022 | Mar 31, 2022 | 54M | +9.3% |
| FY2021 | Mar 31, 2021 | 50M | +55.7% |
| FY2020 | Mar 31, 2020 | 32M | – |
See a number that looks wrong?